Obducat AB has recently confirmed an order for its EITRE 3 nanoimprint lithography (NIL) system, valued at approximately SEK 2.1 million. The anticipated delivery date for this system is set for the second quarter of 2026.
The European institute acquiring the EITRE 3 system plans to utilise it in the research and development of next-generation technologies, particularly within the realms of advanced computing and medical applications. The successful development of these innovative technologies necessitates the creation of extremely small and precise structures. The EITRE 3 system equips the institute with advanced manufacturing capabilities essential for developing and testing solutions through both thermal and UV-based nanoimprint lithography.
Company Overview
Obducat AB (publ) is a pioneering developer and supplier of technologies, products, and processes dedicated to the production and replication of advanced micro and nano structures. The company’s offerings meet the needs of customers across various sectors, including LED and Display, Optics and Photonics, MEMS and Sensor industries, as well as in High Power and High Frequency electronics and Biomedical Devices.
Obducat’s technology portfolio encompasses nano imprint technology, resist-processing, and wet-processing technologies. The company maintains a global presence with operations in Sweden, Germany, Japan, the USA, England, Portugal, and China, with its headquarters located in Lund, Sweden.
As a publicly traded entity, Obducat’s shares are listed on the Swedish NGM Main Regulated Equity exchange. For further details, please visit www.obducat.com or contact via email at investorrelations@obducat.com.
Contact Information
- Henri Bergstrand, Chairman: +46 (0)46-10 16 00 or +46 (0) 708-88 72 45
- Patrik Lundström, CEO: +46 (0)46 10 16 00 or +46 (0) 703 27 37 38